Pacific Biosciences of California (NASDAQ:PACB) Given Overweight Rating at Stephens
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at Stephens in a research note issued to investors on Thursday,Benzinga reports. They currently have a $1.80 target price on the biotechnology company’s stock. Stephens’ price objective would suggest a potential upside of 73.91% from the […]
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at Stephens in a research note issued to investors on Thursday,Benzinga reports. They currently have a $1.80 target price on the biotechnology company’s stock. Stephens’ price objective would suggest a potential upside of 73.91% from the […]
